Unither Pharmaceuticals clinical trials
A subsidiary of United Therapeutics
The registry lists 4 studies whose lead sponsor is Unither Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 18, 2007.
Registry sponsor names on this page
- Unither Pharmaceuticals4 studies
Something wrong with this grouping? Tell us on the United Therapeutics page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All United Therapeutics studies →
- Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian CarcinomaTerminatedNCT00034372Phase 2
Sponsor listed in the registry: Unither Pharmaceuticals
- A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial CarcinomaTerminatedNCT00034138Phase 1/2
Sponsor listed in the registry: Unither Pharmaceuticals
- Clinical Trial for Ovarian Cancer (OvaRex®)TerminatedNCT00050375Phase 3
Sponsor listed in the registry: Unither Pharmaceuticals
- Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer TreatmentTerminatedNCT00086632Phase 2
Sponsor listed in the registry: Unither Pharmaceuticals